PDB17 Comparison of Clinical and Economic Outcomes Associated With Dpp4 Inhibitors (DPP4I) Versus Sulfonylurea (SU) in Combination with Metformin (MET) or Pioglitazone (PIO) for the Treatment of Type 2 Diabetes Mellitus (T2DM)

✍ Scribed by Bron, M.; Chen, K.; Cheng, D.; Bensimon, A.G.; Wu, E.Q.

• Book ID: 122203997
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 68 KB
• Volume: 15
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2012.08.348